Qiagen (NYSE:QGEN) Issues Q1 2025 Earnings Guidance

Qiagen (NYSE:QGEN) updated its first quarter 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 0.500- for the period, compared to the consensus earnings per share estimate of 0.500. The company issued revenue guidance of $472.8 million-, compared to the consensus revenue estimate of $477.5 million. Qiagen also updated its FY 2025 guidance to 2.280- EPS.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on QGEN shares. Hsbc Global Res raised Qiagen to a “hold” rating in a research report on Thursday, October 17th. HSBC downgraded Qiagen from a “buy” rating to a “hold” rating and set a $47.64 price target for the company. in a research note on Thursday, October 17th. Morgan Stanley reissued an “equal weight” rating and issued a $46.67 price objective (down previously from $48.61) on shares of Qiagen in a report on Monday, January 6th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a $52.50 target price (up from $40.83) on shares of Qiagen in a report on Tuesday, December 10th. Four equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $50.07.

Qiagen Stock Up 0.9 %

Shares of QGEN stock traded up $0.40 on Wednesday, hitting $43.76. The stock had a trading volume of 1,533,236 shares, compared to its average volume of 1,163,455. The business has a 50 day moving average price of $43.80 and a 200 day moving average price of $43.26. Qiagen has a one year low of $40.15 and a one year high of $49.30. The company has a market cap of $9.71 billion, a PE ratio of 109.09, a P/E/G ratio of 3.10 and a beta of 0.36. The company has a quick ratio of 1.89, a current ratio of 2.17 and a debt-to-equity ratio of 0.39.

Qiagen (NYSE:QGEN) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.60 by $0.01. Qiagen had a net margin of 4.73% and a return on equity of 13.43%. Research analysts anticipate that Qiagen will post 2.23 earnings per share for the current fiscal year.

Qiagen Company Profile

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.